Stay updated on Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added Melanoma to related topics and MedlinePlus Genetics as related topics on the study page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-21T05:17:21.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added; Melanoma and related topics, including MedlinePlus Genetics and Revision: v3.3.3, were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-14T03:37:26.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-12-23T21:32:34.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Added Melanoma to related topics and included a MedlinePlus Genetics link on the study page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-09T17:37:50.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-12-02T17:23:31.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.2.0 to v3.3.2 on the page.
    Difference
    0.1%
    Check dated 2025-11-25T12:01:17.000Z thumbnail image

Stay in the know with updates to Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial page.